Spreading patterns, prognostic factors and treatment outcomes of nasopharyngeal papillary adenocarcinoma and salivary gland‐type carcinomas
Authors:
- 28 June 2015
- journal article
- research article
- Published by Wiley in Clinical Otolaryngology
- Vol. 41 (2) , 160-168
Abstract
Objectives: In this study, we aim to analyse the different spreading patterns, prognostic factors and treatment outcomes of nasopharyngeal papillary adenocarcinoma (NPAC) and salivary gland‐type carcinomas (NPCs).Design, setting and participant: The current study report on a retrospective analysis of oncologic outcome of 76 pathologically confirmed consecutive cases of nasopharyngeal adenocarcinomas (NAC), including 31 NPAC, 33 adenoid cystic carcinomas (ACC) and 12 mucoepidermoid carcinomas (MEC).Main outcome measure: Overall survival rates (OS) and disease‐free survival rates (DFS).Results: In 12 patients with cranial nerve (CN) palsy, there were ACC (n = 9), NPAC (n = 2) and MEC (n = 1) (P = 0.016). CT‐/MRI‐detected CN involvements were found in 22 patients. Lymph node metastasis was observed in 25.8% of NPAC (n = 8), 12.1% of ACC (n = 4) and 8.3% of MEC (n = 1). Significant differences were observed in 5‐year overall survival (OS) and disease‐free survival (DFS) rates between patients with and without CT‐/MRI‐detected CN involvement (P = 0.002 and P = 0.002, respectively), and similar results were found between patients with and without lymph node metastasis (P = 0.002 and P = 0.018, respectively). In 37 patients with early‐stage disease (stages I–II), significant differences were observed in 5‐year OS and DFS rates between the surgical and non‐surgical treated groups (P = 0.031 and P = 0.012, respectively). In 39 patients with advanced‐stage disease (stages III–IV), significant or marginally differences were observed in DFS and OS between the chemoradiotherapy and non‐chemoradiotherapy groups (P = 0.007 and P = 0.062, respectively).Conclusions: ACC has a higher CN invasion than NPAC and MEC, and NPAC has the highest rate of lymphatic metastases. CT‐/MRI‐detected CN involvements and lymph node metastasis indicate a negative impact on the prognosis. The outcome of surgical patients in our series is encouraging in early‐stage NPAC and NPCs, and chemoradiotherapy may be the optimal treatment for the advanced‐stage patients.Keywords
Funding Information
- National Natural Science Foundation of China (81471711, 81271622)
This publication has 32 references indexed in Scilit:
- Nasopharyngeal mucoepidermoid carcinoma: A case report and review of literatureReports of Practical Oncology and Radiotherapy, 2013
- An endonasal approach to the resection of a papillary seromucinous adenocarcinoma of the Eustacian tubeJournal of Otolaryngology - Head & Neck Surgery, 2013
- Primary nasopharyngeal adenocarcinoma: A reviewAsia-Pacific Journal of Clinical Oncology, 2012
- Multimodal treatment of patients with minor salivary gland cancer in the case of recurrent diseaseHead & Neck, 2010
- Primary salivary gland type carcinoma of the nasopharynx: Therapeutic outcomes and prognostic factorsHead & Neck, 2009
- A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancerClinical Otolaryngology, 2009
- Prognostic impact of magnetic resonance imaging‐detected cranial nerve involvement in nasopharyngeal carcinomaCancer, 2009
- Adenoid Cystic Carcinoma of the Nasopharynx: 27‐Year ExperienceThe Laryngoscope, 2008
- Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinomaActa Oto-Laryngologica, 2006
- Management of Nasopharyngeal Salivary Gland MalignancyThe Laryngoscope, 2001